PharmaCorp Rx Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 9, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	73	63	4	12	-
Market Cap Growth	25.24%	1387.38%	-64.51%	-	-
Enterprise Value	73	38	2	9	-
Last Close Price	0.44	0.54	0.21	0.60	-
PS Ratio	4.17	10.93	-	-	-
PB Ratio	2.43	2.07	1.87	4.42	-
P/TBV Ratio	9.18	4.61	1.87	4.42	-
P/FCF Ratio	47.72	536.42	-	-	-
P/OCF Ratio	45.69	506.85	-	-	-
EV/Sales Ratio	4.15	6.54	-	-	-
EV/FCF Ratio	47.41	321.02	-	-	-
Debt / Equity Ratio	0.14	0.03	-	-	-
Debt / FCF Ratio	2.81	8.07	-	-	-
Net Debt / Equity Ratio	-0.02	-0.39	-0.99	-1.01	-1.01
Net Debt / EBITDA Ratio	-1.65	8.86	-	-	-
Net Debt / FCF Ratio	-0.46	-101.06	4.32	22.74	-622.24
Asset Turnover	0.49	0.31	-	-	-
Quick Ratio	1.74	7.79	48.54	166.01	37.20
Current Ratio	2.53	8.59	50.24	166.01	37.98
Return on Equity (ROE)	0.61%	-6.40%	-18.85%	-28.02%	-
Return on Assets (ROA)	-0.42%	-5.29%	-14.29%	-18.85%	-
Return on Capital Employed (ROCE)	-0.70%	-4.70%	-25.40%	-20.70%	-8.20%
Earnings Yield	0.26%	-1.60%	-11.05%	-4.31%	-
FCF Yield	2.10%	0.19%	-12.20%	-1.00%	-
Buyback Yield / Dilution	-0.34%	-303.02%	-1.39%	-23.69%	-

Source: S&P Capital IQ. Standard template. Financial Sources.